Related by context. All words. (Click for frequent words.) 77 Prolongs Survival 77 Fungal Infections 76 Topical Treatment 76 Oral Mucositis 75 Treating Chronic 75 Clinical Outcome 74 Adjuvant Chemotherapy 74 Atopic Dermatitis 74 Complicated Skin 74 Advanced Melanoma 74 Chemotherapy Induced 74 Single Dose 74 Proven Effective 74 Improves Outcomes 74 Long Term Efficacy 73 Adjuvant Treatment 73 Posaconazole 73 HER2 Positive 73 See CLINICAL PHARMACOLOGY 73 Virus Infection 73 Shows Efficacy 73 Combo Therapy 73 Adjuvant Therapy 73 Demonstrates Efficacy 73 Fondaparinux 72 Antitumor 72 Appears Safe 72 Combination Treatment 72 Chronic Hepatitis B 72 Prophylactic Treatment 72 Bone Metastases 72 Seasonal Influenza Vaccine 72 Improves Survival 72 Osteoporosis Treatment 72 Shows Promising 72 Study Evaluating 72 Meets Primary Endpoint 72 Potentially Fatal 72 Efficacy Trial 72 Shows Promise Against 72 Venous Thromboembolism 72 Cocaine Addiction 72 Combination Therapy 72 Chronic Sinusitis 72 Oral Fingolimod 72 Allergic Rhinitis 72 Patients Receiving 72 Patients Treated With 72 Breast Cancer Recurrence 72 Investigational Treatment 71 Metastatic Colorectal Cancer 71 Vaginal Gel 71 Treatment Naive Patients 71 Novel Compound 71 Lowers Risk 71 Newly Diagnosed Multiple Myeloma 71 Chronic Hepatitis C 71 Community Acquired Pneumonia 71 Mouse Model 71 Demonstrates Significant 71 Hospital Acquired Pneumonia 71 Lung Cancer Survival 71 Gastric Cancer 71 Inhaled Corticosteroids 71 Meta Analysis 71 Pediatric Patients 71 Overactive Bladder 71 Unfractionated Heparin 71 Treated Patients 71 Phase IIb Trial 71 Prospective Randomized 71 Phase 2b Clinical Trial 71 Enlarged Prostate 71 Uterine Cancer 71 Is Well Tolerated 71 Proves Effective 71 Hormone Receptor Positive 71 Effectively Treats 71 Anticoagulant 71 Fracture Risk 71 Rheumatoid Arthritis Patients 71 FDA Approvals 71 Investigational Agent 71 Myelodysplastic Syndromes 71 Receives Orphan Drug Designation 70 Trial Evaluating 70 Patients Undergoing 70 Thromboembolic 70 Demonstrates Sustained 70 Benign Prostatic Hyperplasia 70 Shown Effective 70 Progenitor Cells 70 Bloodstream Infections 70 Minimally Invasive Treatment 70 Inflammatory Arthritis 70 Thromboembolism 70 Protease Inhibitor 70 Demonstrates Positive 70 Tumor Growth 70 Allogeneic 70 Advanced Renal Cell 70 Pooled Analysis 70 Node Positive 70 Cholesterol Lowering Drug 70 Expanded Indication 70 Immune Mediated 70 Drug Shows Promise 70 Reduces Pain 70 Blood Clotting 70 Postmenopausal Osteoporosis 70 IND Application 70 Beta Blocker 70 Tyrosine Kinase Inhibitor 70 Skin Lesions 70 Treatment Reduces 70 Knee Osteoarthritis 70 Invasive Breast Cancer 70 Reduces Risk 70 Experimental Vaccine 70 Oral Cavity 70 Brain Metastases 70 Therapy Reduces 70 Renal Cell Carcinoma 70 Significantly Improved 70 Skin Structure Infections 70 Test Detects 70 Inflammatory Markers 70 Metastatic Prostate Cancer 70 Phase III Clinical Trial 70 Kidney Function 70 Advanced Prostate Cancer 70 Critically Ill Patients 70 Vitro Activity 70 Relapsing Multiple Sclerosis 70 Chronic Renal Failure 70 Study Demonstrates 69 Rotavirus Vaccine 69 Renal Cancer 69 Lowers Blood Pressure 69 Antitumor Activity 69 Novel Oral 69 Prognostic Factors 69 Multiple Myeloma Patients 69 Antiplatelet 69 Breast Cancer Cells 69 Subgroup Analysis 69 Relapsing Remitting Multiple Sclerosis 69 Breast Tumor 69 Tacrolimus 69 Coronary Arteries 69 Nebulized 69 Adjunctive Therapy 69 Immune Responses 69 Neuroendocrine Tumors 69 Catheter Associated 69 Reduces Mortality 69 Thrombotic 69 Elderly Patients 69 Immunosuppressant 69 Recurrent Breast Cancer 69 Lymphoid 69 Infected Patients 69 Pharmacokinetic Study 69 Oropharyngeal Candidiasis 69 Susceptibility Testing 69 Analytical Tool 69 Secondary Hyperparathyroidism 69 Clinical Trial Results 69 Resistant Hypertension 69 Systematic Review 69 Antifungal 69 Pulmonary Arterial Hypertension 69 Vascular Grafts 69 Significantly Improves 69 Patients Treated 69 Drug Resistant 69 Chronic Heart Failure 69 Anti Inflammatory Drug 69 Disease Progression 69 Inflammatory Pain 69 Neoadjuvant Chemotherapy 69 Initiates Clinical Trial 69 Drug Candidate 69 Diabetic Foot Ulcer 69 Genes Predict 69 Teva Provides Update 69 Study Evaluates 69 Hepatocellular Carcinoma 69 Neoplasms 69 Percutaneous Tibial Nerve Stimulation 69 Fewer Side Effects 69 Low Dose 69 Severe Asthma 69 Heart Failure Patients 69 Placebo Controlled Study 69 Improve Survival 69 Helicobacter Pylori 69 Coronary Disease 69 Showed Significant 69 Controlled Trial 69 Drug Combinations 69 Peginterferon 69 Endometrial Cancer 69 Therapy Shows Promise 69 Erythropoietic 69 Sevelamer 69 Randomized Clinical Trials 69 Antibiotic Resistant 69 Symptom Relief 69 Prolongs Life 69 Mucosal 69 Improved Survival 69 Aggressive Prostate Cancer 69 Severe Sepsis 69 Plus Ribavirin 69 Genital Warts 69 C1 Inhibitor 69 Non Invasive Treatment 69 Stent Placement 69 Anti Tumor 69 Transdermal Patch 69 Non Responders 69 HER2 Positive Breast Cancer 69 Protein Linked 68 Postherpetic Neuralgia 68 Therapy Improves 68 Platelet Function 68 Mylan Receives Approval 68 Bone Fractures 68 Tumor Cell 68 Slow Progression 68 Pregnancy Outcomes 68 Radiation Induced 68 Colorectal Adenomas 68 Epidermal Growth Factor Receptor 68 Orthostatic Hypotension 68 Psoriasis Drug 68 Demonstrates Statistically Significant 68 Kidney Transplant Patients 68 Protein Involved 68 Recurrent Stroke 68 Quantitation 68 Malignant Melanoma 68 Phase III Trial 68 Left Ventricular 68 Lupus Nephritis 68 Hematological Cancers 68 Hypertensive Patients 68 Embolization 68 Bacterial Infection 68 Schizophrenia Treatment 68 Statistically Significant 68 Patients Suffering 68 Autologous Stem Cell Transplantation 68 Cold Sore 68 Demonstrated Significant 68 Fibrinogen 68 Soft Tissue Sarcoma 68 Pneumococcal Disease 68 Chagas Disease 68 Ischemic 68 #-# Full Text 68 Postmenopausal Women 68 Vitrasert R 68 Demonstrate Significant 68 Epilepsy Drug 68 Hypercholesterolemia 68 Urinary Tract Infections 68 Prophylaxis 68 Improve Outcomes 68 Randomized Trials 68 Gram Positive 68 Monotherapy 68 Novel Vaccine 68 Bacterial Infections 68 Fibromyalgia Pain 68 Lung Injury 68 Subtypes 68 Therapeutic Efficacy 68 Prostate Cancer Vaccine 68 Androgen Deprivation Therapy 68 Previously Treated 68 Follicular Lymphoma 68 Skeletal Muscle 68 Novel Mechanism 68 Immunotherapeutic 68 Replacement Therapy 68 dual endothelin receptor antagonist 68 Double Blind Randomized 68 FDA Accepts 68 Randomized Study 68 Hepatitis B Virus 68 Statin Drugs 68 Peripheral Arterial 68 Lubiprostone 68 ORLive Presents 68 American Migraine Prevalence 68 Tiotropium 68 ACE Inhibitors 68 Localized Prostate Cancer 68 Autoimmune Disorders 68 Breast Tumors 68 Investigational Compound 68 Survival Benefit 68 Patient Enrollment 68 NDA Submission 68 Antiviral Drugs 68 Lymphocytic 68 Monoclonal Antibody 68 Controlled Study 68 Adenoma 68 Guidelines Issued 68 Initiate Clinical Trial 68 Contrast Induced Nephropathy 68 Submits NDA 68 Coronary Angiography 68 FDA Approves Drug 68 Significantly Reduces 68 Inflammatory Disease 68 Kidney Transplant Recipients 68 Intravenous Formulation 68 Osteoporosis Drugs 68 Preterm Labor 68 Chronic Bronchitis 68 Hormone Refractory Prostate Cancer 67 Shows Statistically Significant 67 Viral Load 67 Cognitive Impairment 67 Efficacious 67 HCV Protease Inhibitor 67 Protease Inhibitors 67 Vaccine Candidate 67 Carotid Stenting 67 Fixed Dose 67 Signaling Pathway 67 Iron Deficiency 67 Deep Venous Thrombosis 67 Adverse Event 67 Advanced Colorectal Cancer 67 Statin Therapy 67 TB Vaccine 67 Malignant Glioma 67 Investigational Drug 67 Refractory Hodgkin Lymphoma 67 Autoimmune Disease 67 Uric Acid 67 Bacteremia 67 FDA Clears 67 Serious Infections 67 JAK Inhibitor 67 Anti Tumor Activity 67 Blood Pressure Drug 67 FDA Okays 67 Long Term Survival 67 Novel Antibiotic 67 Hepatic Encephalopathy 67 Cardiovascular Disease Risk 67 Novel Inhibitor 67 Premenopausal Women 67 Achieves Primary Endpoint 67 Reduced Risk 67 Sustained Release 67 Lung Infections 67 Phase 2b Trial 67 Growth Hormone Deficiency 67 Autoimmune Diseases 67 Phase 2a Trial 67 Febrile Neutropenia 67 Drug Prevents 67 Gout Drug 67 Cardiovascular Events 67 Diabetic Neuropathy 67 Lung Cancer Drug 67 Helps Predict 67 Laryngeal Cancer 67 Moxifloxacin 67 Dry Powder Inhalers 67 Fixed Dose Combination 67 Clinical Evaluation 67 Increased Mortality 67 Mg Usa 67 Progressive Multifocal Leukoencephalopathy 67 Generic Versions 67 Contrast Agents 67 Atypical Hemolytic Uremic Syndrome 67 Stomach Cancer 67 Interferon Beta 67 Generic Version 67 Genes Linked 67 Completes Patient Enrollment 67 Fast Track Status 67 FDA Warns Against 67 Phase 2b Study 67 Less Invasive 67 NOXAFIL 67 Parenteral Nutrition 67 5 Fluorouracil 67 Successfully Treated 67 Clostridium difficile Infection 67 Granted Orphan Drug 67 Randomized Controlled Trials 67 Diagnosis Treatment 67 Pneumococcal Vaccine 67 Impairs 67 Stress Incontinence 67 Treatment Experienced 67 Demonstrates Potent 67 Drug Combo 67 Eculizumab 67 Commonly Used 67 Renal Artery 67 Treatment Shows Promise 67 Minimally Invasive Procedure 67 Tigecycline 67 Diagnostic Tests 67 Testosterone Patch 67 Recombinant Human 67 Septic Shock 67 Therapeutic Vaccine 67 Hsp# Inhibitor 67 Drug Regimen 67 Transdermal Delivery 67 Dupuytren Contracture 67 TNF Tumor Necrosis Factor 67 Clinical Efficacy 67 Portal Hypertension 67 Preterm Delivery 67 Tissue Engineered 67 Blood Cancers 67 Bazedoxifene 67 Data Suggest 67 Myeloma Patients 67 Elevated Levels 67 Successfully Completes Phase 67 Phase 2a Clinical Trial 67 Metabolic Disorder 67 Lanthanum Carbonate 67 Respiratory Infections 67 First Patient Treated 67 Diabetic Patients 67 Novel Therapeutic 67 Maleate 67 FDA Panel Recommends 67 Muscle Function 67 Stakeholder Opinions 67 Immunomedics Announces 67 Lung Cancer Patients 67 Advanced Pancreatic Cancer 67 Surgical Procedures 67 Arterial Disease 67 Inhaled Nitric Oxide 67 Migraine Headaches 67 Prove Effective 67 Antiviral Therapy 67 Vertebral Fracture 67 Multidrug Resistant 67 Hematopoietic 67 Cancer Recurrence 67 Stress Urinary Incontinence 67 Genital Herpes 67 Non Inferiority 67 Artery Disease 67 Begin Clinical Trials 67 See WARNINGS 67 Peginterferon Alfa 2a 67 Epilepsy Drugs 67 RNAi Therapeutic 67 Nucleoside 67 Prostate Tumors 67 Contrast Agent 67 Obesity Linked 67 Cardiovascular Outcomes 67 Chronic Liver Disease 67 Allergic Reactions 67 Confirmatory Phase 67 Radiofrequency Ablation 67 Hospitalized Patients 67 Inhibits 67 FDA APPROVES 67 Peptic Ulcer 67 Tuberculosis Vaccine 67 Potent Antiviral Activity 67 Colorectal Cancer Patients 67 Ischemic Stroke 66 Crit Rev 66 Chronic Lymphocytic Leukemia 66 Bosutinib 66 Genetic Variation 66 Slows Progression 66 Nicotine Vaccine 66 Bivalirudin 66 Tumor Targeting 66 Myelofibrosis 66 Retinal Vein Occlusion 66 Treatment Regimen 66 Strongly Linked 66 Genetic Marker 66 Antibiotic Treatment 66 Excessive Sweating 66 Pre Cancerous 66 Menopausal Symptoms 66 Premature Infants 66 TNF Blockers 66 Migraine Pain 66 Idiopathic Pulmonary Fibrosis 66 Allergic Asthma 66 Placebo Controlled Trial 66 Oncolytic 66 Chronic Lung 66 Circulating Tumor Cells 66 Tumor Progression 66 Periodontal Disease 66 MRSA Infections 66 Sleep Disturbances 66 Angiogenic 66 Diabetic Foot Ulcers 66 Aliskiren 66 Preclinical Study 66 Well Tolerated 66 Ranolazine 66 Respiratory Virus 66 Plaque Psoriasis 66 Receives Marketing Authorization 66 Insulin Glargine 66 Clinical Trial Evaluating 66 Hepatitis C Genotype 66 Prostate Cancer Patients 66 Taxane 66 Prostatic 66 Coronary Stents 66 J Pediatr 66 Liver Injury 66 Diabetic Nephropathy 66 Melphalan 66 Enoxaparin 66 Renal Impairment 66 Gene Variation 66 Study Shows Benefits 66 Breast Cancer Metastasis 66 Prognostic Significance 66 Thrombus 66 Ebola Vaccine 66 Gum Disease 66 Cold Sores 66 Receives Positive Opinion 66 Fluticasone 66 Significant Improvements 66 Liver Failure 66 J Clin 66 Cell Transplants 66 Interferon Alfa 66 Surgical Treatment 66 Stem Cell Treatment 66 Curr Opin 66 Leukemia Cells 66 Obese Patients 66 Acute Pancreatitis 66 Regimens 66 Noxafil 66 Epithelial Cell 66 Treatment Naïve Patients 66 #mg Tablets [002] 66 Rhinosinusitis 66 Adenoviral 66 Modulates 66 Regenerative Cells 66 Myocardial Ischemia 66 Breast Cancer Stem Cells 66 Estrogen Therapy 66 Inflammatory Diseases 66 Asthma COPD 66 Phase IIa Clinical Trial 66 #:#-# [037] 66 VIVITROL ® 66 Sustained Efficacy 66 Pharmacokinetics PK 66 Smooth Muscle 66 Unresectable 66 Relapsed Refractory 66 CT Angiography 66 Acute Coronary Syndromes 66 Anthracycline 66 Stent Coating 66 Hepatitis C Patients 66 Gene Variant 66 Adjunctive 66 Eur J 66 Juvenile Idiopathic Arthritis 66 Lupus Drug 66 Lung Tumors 66 Acute Heart Failure 66 Treatment Naïve 66 Dehydrogenase 66 Breast Cancer Treatment 66 Mg Uk 66 Intracranial Aneurysms 66 Ovarian Cancers 66 Therapeutic Antibody 66 Itraconazole 66 Mycophenolate Mofetil 66 Drug Coated Stents 66 Therapeutic Potential 66 Renal Anemia 66 Phospholipase A2 66 Levels Linked 66 Increases Risk 66 Irritable Bowel 66 Diagnostic Criteria 66 Pressure Ulcers 66 Antifungals 66 Embolic 66 Suicidality 66 ergot derivatives 66 Helps Identify 66 PROCRIT R 66 Partial Onset Seizures 66 Muscle Wasting 66 Therapeutic Effects 66 Improves Quality 66 Colon Polyps 66 Novel Treatments 66 Alternative Treatments 66 Positive Opinion 66 Radioimmunotherapy 66 Study Casts Doubt 66 Metastatic Melanoma 66 Breast Cancers 66 Helps Relieve 66 Vertebral Compression Fractures 66 Cognitive Function 66 Blood Flow 66 ARIXTRA R 66 Drug Eluting 66 Acute Ischemic Stroke 66 Epoetin Alfa 66 Demonstrates Superior 66 Topical Cream 66 Immune Cells 66 Gastrointestinal Disorders 66 Improve Patient Outcomes 66 Clinically Significant 66 Multicenter Study 66 Targeted Therapy 66 Files IND 66 SARS Virus 66 #:#-# [023] 66 Holds Promise 66 Tumor Response 66 Clinical Trial Data 66 von Willebrand Factor 66 Restenosis 66 Antimicrobial Coating 66 Urine Test 66 Vaccine Adjuvant 66 Previously Untreated 66 Mouse Models 66 Prognostic Value 66 Being Studied 66 Fecal Incontinence 66 Could Save Lives 66 Treatment Resistant 66 NAVISTAR R 66 Preterm Infants 66 Anticancer Activity 66 Non Alcoholic Fatty 66 Significant Improvement 66 Nail Fungus 65 Dose Response 65 Aortic Aneurysm 65 Naive Patients 65 Genetic Mutation 65 Acne Scars 65 Preclinical Data 65 Fluorouracil 65 Blood Thinner 65 Heart Stents 65 Oral Formulation 65 Anthrax Toxin 65 Hematopoietic Stem Cells 65 Iron Overload 65 Significant Reduction 65 Virus Linked 65 FOR WELL BEING 65 Physician Insights 65 Severe Acne 65 Venous Thrombosis 65 Pulmonary Artery 65 Study Proves 65 Randomized Clinical Trial 65 Beta Blockers 65 Intravascular 65 Therapeutic Intervention 65 Abdominal Pain 65 Bacterial Vaginosis 65 Osteoporosis Drug 65 Spinal Fusion 65 Anti Angiogenesis 65 Significantly Reduced 65 Acute Pain 65 Study Showed 65 Myocardial Perfusion Imaging 65 Parathyroid Hormone 65 Cigarette Smoke 65 Blood Clot Risk 65 Asthma Treatment 65 Attenuates 65 Chronic Pelvic Pain 65 Paraplatin ® 65 Randomized Double Blind 65 abacavir sulfate lamivudine 65 Viral Infection 65 Gene Mutation 65 BioElectronics Announces 65 Glatiramer Acetate 65 J Am Coll 65 Linezolid 65 Relieve Pain 65 Antimicrobial Activity 65 Embolic Protection Device 65 Bronchopulmonary Dysplasia 65 Acute Myocardial Infarction 65 Intracerebral Hemorrhage 65 Oral Insulin 65 Interferon Alpha 65 Cardiovasc 65 Fluconazole 65 Peripheral Blood 65 Rilonacept 65 Improve Diagnosis 65 Catheter Ablation 65 Chronic HCV 65 Ultrasound Guided 65 Antibacterials 65 Blepharospasm 65 Macrolide 65 IN PATIENTS WITH 65 Abdominal Fat 65 Benign Prostatic Hyperplasia BPH 65 Hormonal Therapy 65 Bladder Cancer 65 Immunosuppression 65 Metastatic Renal Cell Carcinoma 65 Hemorrhagic Stroke 65 Factor Xa Inhibitor 65 Cutaneous T 65 Clinical Outcomes 65 Rheumatoid Arthritis Drug 65 Oral Calcitonin 65 Contrast Enhanced 65 Rabies Vaccine 65 Immunomodulatory 65 Phase III Clinical Trials 65 Lung Cancer Trial 65 Pegylated 65 Antibiotic Use 65 Polymerase Inhibitor 65 Microspheres 65 Pegylated Liposomal Doxorubicin 65 Renal Function 65 Levofloxacin 65 Live Attenuated 65 Skin Cancers 65 Pneumonia Vaccine 65 Erectile Dysfunction Drug 65 Initiate Phase III 65 Factor Receptor 65 Radical Prostatectomy 65 Osteoarthritis Patients 65 Etanercept 65 Clinically Proven 65 Sustained Reduction 65 Brain Aneurysms 65 Cancer Treatments 65 Neuroprotective Effects 65 Lymph Node 65 Predict Breast Cancer 65 Diabetic Neuropathic Pain 65 Non Alcoholic Steatohepatitis 65 Cyclooxygenase 2 65 Develops Novel 65 Stable Angina 65 Interferon Gamma 65 Beneficial Effects 65 Antigen Specific 65 Avian Flu Vaccine 65 Sinus Infections 65 Prenatal Diagnosis 65 Often Misdiagnosed 65 Insulin Sensitivity 65 Anemia Drug 65 Immunogenicity 65 Antiepileptic Drug 65 Node Negative 65 Head Lice Treatment 65 Antiplatelet Therapy 65 Oral Anticoagulant 65 ST Segment Elevation 65 Solid Tumors 65 Conjugate 65 Hepatitis C Virus 65 Oral Spray 65 Dengue Virus 65 Predict Risk 65 Prevent Stroke 65 Erosive Esophagitis 65 Antiviral Drug 65 Atypical Antipsychotic 65 Protein Synthesis 65 Viral Infections 65 Extended Release 65 Brain Shrinkage 65 Vertebral Fractures 65 Postdoctoral Position 65 Clinical Trial Enrollment 65 Confirms Efficacy 65 Alpha interferons including 65 MR Angiography 65 Advanced Ovarian Cancer 65 Chemotherapeutic Agents 65 Skin Disorders 65 Pract 65 Stent Restenosis 65 Endovascular Treatment 65 Human Monoclonal Antibody 65 Int J 65 First Patient Dosed 65 Hip Fractures 65 Study Shows Promise 65 Irinotecan 65 Medication Adherence 65 Receives Approvable Letter 65 Oral Interferon 65 Vaccine Protects Against 65 Intracerebral 65 Cyclophosphamide 65 Carotid Endarterectomy 65 Causes Symptoms 65 Bronchodilator 65 Ultrasensitive 65 Menstrual Pain 65 Based Regimens 65 Pelvic Organ Prolapse 65 Hematological 65 Quadrivalent 65 Pafuramidine 65 Effective Treatments 65 sunitinib Sutent ® 65 Blood Clots 65 Post Operative 65 Dermatol 65 Delayed Graft Function 65 Respiratory Syncytial Virus 65 Cytotoxic 65 Cilostazol 65 Proton Pump Inhibitors 65 Bare Metal Stent 65 Bipolar Mania 65 Chronic Inflammation 65 Intravenous Immunoglobulin 65 Shoulder Prosthesis 65 Organ Rejection 65 Diet Supplements 65 Study Shows Significant 65 Key Attributes 65 Telaprevir VX 65 Dual Antiplatelet Therapy 65 Diastolic Heart Failure 65 Shows Promise 65 Montelukast 65 Tumor Cells 65 Anti Clotting Drug 65 Bevacizumab 65 Medoxomil 65 Emerging Therapies 65 Mimetics 65 Radiofrequency Ablation RFA 65 Tesamorelin 65 Electrical Stimulation 65 Migraine Treatment 65 Versus Placebo 65 Daptomycin 65 Cholesterol Lowering 65 #:#-# [031] 65 Cervical Disease 65 Induces 65 Liver Tumors 65 Iron Deficiency Anemia 65 BioSante Pharmaceuticals Reports 65 Endometrial 65 Cardiac Resynchronization 65 Nilotinib 65 Breast Density 65 Antiviral Activity 65 Systemic Delivery 65 Phase Ib Clinical Trial 64 Obese Teens 64 Premature Ejaculation 64 Lymphoma Patients 64 Smallpox Vaccine 64 Leukemias 64 Hepatitis C Infection 64 Combination REOLYSIN R 64 Hazardous Drugs 64 II Clinical Trial 64 Chemoradiation 64 Potentially Deadly 64 Cardiotoxicity 64 Potent Inhibitor 64 Electrophysiology Mapping 64 Mortality Risk 64 Chronic Constipation 64 undergoing Percutaneous Coronary 64 Budesonide 64 Hepatotoxicity 64 Castration Resistant Prostate Cancer 64 oropharyngeal candidiasis OPC 64 ST Elevation Myocardial 64 Bone Grafts 64 Therapy Evaluation 64 Lung Cancers 64 Non Invasive 64 Decompensated Heart Failure 64 Clinically Tested 64 Anticancer Drugs 64 #:#-# [007] 64 Dose Escalation 64 External Beam 64 Panic Disorder 64 Completes Enrollment 64 Adult Stem Cell Therapy 64 Endocarditis 64 Boosts Survival 64 Palonosetron 64 Inhalation Solution 64 Vitamin D Deficiency 64 Wound Closure 64 R lenalidomide 64 Eradicates 64 Wound Dressing 64 Demonstrates Potential 64 Seasonal Allergic Rhinitis 64 Ascites 64 Molecular Mechanism 64 Who Underwent 64 Announces FDA Clearance 64 J Am Acad 64 adalimumab Humira 64 Bepreve TM 64 Detect Cancer 64 Aortic Stenosis 64 Depressive Symptoms 64 Faropenem 64 Autoantibodies 64 Neoadjuvant 64 Pediatr 64 Desvenlafaxine Succinate 64 Newly Diagnosed Breast Cancer 64 Fatty Liver 64 Nat Clin Pract 64 lexidronam injection 64 Chronic Prostatitis 64 Respiratory Distress 64 Cerebrospinal Fluid 64 Retinoic Acid 64 Ascorbic Acid 64 Conjugated 64 Vasomotor Symptoms 64 Postmenopausal 64 Anesth 64 Orally Active 64 Fibrin Sealant Human 64 Hormone Therapy 64 First Patient Enrolled 64 Kinase Inhibitor 64 Psoriasis Patients 64 Chemoprevention 64 Sirolimus Eluting Stent 64 Predict Response 64 Pivotal Trial 64 Genes Involved 64 Cannabinoid 64 Combination Therapies 64 Vaccine Shows Promise 64 Azathioprine 64 Gastrointestinal Stromal Tumors 64 STELARA TM 64 OSMOPREP TM 64 Hepatocellular 64 Novel Method 64 Cardiogenic Shock 64 Sipuleucel T 64 Eye Infections 64 Left Atrial 64 Liver Cirrhosis 64 Viral Suppression 64 Remission Maintenance 64 Stress Induced 64 Romiplostim 64 Cardiol